Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Almirall S.A.
0O9BCurrent price
9.02 EUR
0 EUR (0.00%)
Last closed
9 EUR
Company
www.almirall.com
ISIN
ES0157097017
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
London Exchange
Capitalization
1 930 308 453 EUR
Yield for 12 month
+6.80 %
1Y
3Y
5Y
10Y
15Y
0O9B
Almirall, S.A., a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations. It has a multi-target alliance with Etherna to research and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer. The company was formerly known as Laboratorios Almirall, S.A. and changed its name to Almirall, S.A. in May 2009. Almirall, S.A. was founded in 1943 and is headquartered in Barcelona, Spain. Address: Ronda General Mitre, 151, Barcelona, Spain, 08022
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
12.4 EURP/E ratio
–Dividend Yield
1.64 %Current Year
+893 954 900 EUR
Last Year
+858 594 548 EUR
Current Quarter
+494 537 681 EUR
Last Quarter
+247 458 811 EUR
Current Year
+578 265 887 EUR
Last Year
+677 111 161 EUR
Current Quarter
+202 477 602 EUR
Last Quarter
+157 745 046 EUR
Key Figures 0O9B
1 year
3 years
5 years
10 years
EBITDA
148 884 079 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
1.11 %
PEG Ratio
0.2956
Return On Equity TTM
-2.33 %
Wall Street Target Price
12.4 EUR
Revenue TTM
926 607 942 EUR
Book Value
6.93 EUR
Revenue Per Share TTM
Dividend Share
0.19 EUR
Quarterly Revenue Growth YOY
7 %
Dividend Yield
1.64 %
Gross Profit TTM
671 987 928 EUR
Earnings per share
-0.19 EUR
Diluted Eps TTM
-0.19 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
65.6 %
Profit Margin
-3.77 %
Dividend Analytics 0O9B
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
112 %Dividend History 0O9B
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.18
Ex Dividend Date
17.05.2024
Forward Annual Dividend Yield
2.04 %
Last Split Factor
47:46
Payout Ratio
1.66 %
Last Split Date
14.09.2020
Dividend Date
–
Stock Valuation 0O9B
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
15.2905
Enterprise Value Revenue
2.1622
Price Sales TTM
2.0832
Enterprise Value EBITDA
16.2852
Price Book MRQ
1.2941
Financials 0O9B
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0O9B
For 52 weeks
7.69 EUR
9.99 EUR
50 Day MA
8.8 EUR
Shares Short Prior Month
–
200 Day MA
8.81 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart